publication . Other literature type . 2018

The use of Nexobridtm in debriding chronic ulcers: a preliminary observational study

Mataro, I.; Giudice, G.; D’Alessio, R.; Maggio, G.; Vestita, M.;
Open Access English
  • Published: 30 Jun 2018
  • Publisher: Euro-Mediterranean Council for Burns and Fire Disasters - MBC
Nexobrid is a highly selective enzymatic debriding agent used in the acute management of burns to perform escharectomy. From October 2016 to April 2017, we treated 6 patients affected with lower limb chronic ulcers of different etiologies with Nexobrid in order to perform eschar removal by enzymatic debridement. For all patients, a dosage of Nexobrid, calculated as 2gr per 1% TBSA, was applied in a 2-3 mm thick uniform layer on the ulcer eschar and fibrin tissue and left for 4 hours, covered with an occlusive dressing. Patients were assessed in terms of ulcer cleansing 24 hours and 7 days post Nexobrid debridement, by wound bed score (WBS) and % of remaining nec...
free text keywords: Research Article
Download from
Europe PubMed Central
Other literature type . 2018
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue